Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
120.92
+0.74 (0.62%)
At close: Jun 13, 2025, 4:00 PM
120.92
0.00 (0.00%)
After-hours: Jun 13, 2025, 4:10 PM EDT
Encompass Health Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Encompass Health stock ranges from a low of $100 to a high of $135. The average analyst price target of $123.38 forecasts a 2.03% increase in the stock price over the next year.
Price Target: $123.38 (+2.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Encompass Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 4 | 5 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $135 | Buy | Reiterates | $135 | +11.64% | Jun 5, 2025 |
| Keybanc | Keybanc | Buy Maintains $122 → $135 | Buy | Maintains | $122 → $135 | +11.64% | May 27, 2025 |
| UBS | UBS | Strong Buy Maintains $117 → $130 | Strong Buy | Maintains | $117 → $130 | +7.51% | Apr 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $110 → $125 | Buy | Maintains | $110 → $125 | +3.37% | Apr 28, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $116 → $135 | Strong Buy | Reiterates | $116 → $135 | +11.64% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
5.95B
from 5.37B
Increased by 10.73%
Revenue Next Year
6.46B
from 5.95B
Increased by 8.55%
EPS This Year
5.06
from 4.46
Increased by 13.54%
EPS Next Year
5.65
from 5.06
Increased by 11.60%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.2B | 6.7B | 7.3B | |
| Avg | 6.0B | 6.5B | 6.9B | |
| Low | 5.7B | 6.2B | 6.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 15.7% | 13.4% | 13.0% | |
| Avg | 10.7% | 8.6% | 7.5% | |
| Low | 6.9% | 4.5% | 3.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 5.33 | 6.34 | 6.99 | |
| Avg | 5.06 | 5.65 | 6.19 | |
| Low | 4.83 | 5.24 | 5.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 19.6% | 25.3% | 23.8% | |
| Avg | 13.5% | 11.6% | 9.5% | |
| Low | 8.4% | 3.6% | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.